KEROS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.86 USD | +6.77% |
|
-0.72% | +45.52% |
| 03-19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
| 03-15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 55.19 $ | 56.24 $ | 54.19 $ | 57.86 $ |
| Volume | 478 427 | 311 717 | 261 556 | 291 970 |
| Change | -1.06% | +1.90% | -3.65% | +6.77% |
| Opening | 56.15 | 55.56 | 55.05 | 54.68 |
| High | 58.69 | 57.60 | 55.05 | 58.45 |
| Low | 54.93 | 55.21 | 53.24 | 53.69 |
Performance
| 1 day | +6.77% | ||
| 1 week | -0.72% | ||
| Current month | -12.60% | ||
| 1 month | -12.60% | ||
| 3 months | +1.05% | ||
| 6 months | +109.18% | ||
| Current year | +45.52% | ||
| 1 year | +30.45% | ||
| 3 years | -14.74% |
Volumes
marketsDaily volume
291 970
Estimated daily volume
291 970
Avg. Volume 20 sessions
288 390
Daily volume ratio
1.01
Avg. Volume 20 sessions USD
16 686 245.40
Record volume 1
2 416 753
Record volume 2
1 889 296
Record volume 3
1 862 879
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
2 086 882 097
Net sales (USD)
151 000
Number of employees
136
Sales / Employee (USD)
1 110
Free-Float
93.64 %
Free-Float capitalization (USD)
1 954 121 054
Average Daily Capital Traded
0.8%
Highs and lows
1 week
53.24
58.69
1 month
53.2467.30
Current year
39.0073.00
1 year
27.0273.00
3 years
24.3873.00
5 years
19.1088.80
10 years
19.1088.80
Indicators
Moving average 5 days
55.86
Moving average 20 days
60.37
Moving average 50 days
63.46
Moving average 100 days
54.77
Price spread / (MMA5)
-3.45%
Price spread / (MMA20)
+4.34%
Price spread / (MMA50)
+9.68%
Price spread / (MMA100)
-5.34%
STIM
RSI 9 days
27.69
RSI 14 days
33.34
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +6.77% | -0.72% | +45.52% | +30.45% | 2.09B | ||
| -0.06% | +0.81% | -2.31% | +16.66% | 103B | ||
| -0.84% | -1.52% | +0.56% | +10.15% | 95.28B | ||
| -1.12% | +2.46% | +0.55% | -4.14% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -23.66% | 21.02B | ||
| +0.68% | -3.00% | -8.63% | -29.53% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.44% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.76% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +34.59% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +4.89% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.07% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +248.71% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +94.25% | 7.76B | ||
| +0.84% | +0.62% | +0.17% | +46.25% | 7.71B | ||
| +3.56% | +9.06% | -52.84% | -69.98% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +29.51% | 6.99B | ||
| Average | +1.65% | +3.74% | +14.24% | +17.37% | ||
| Weighted average by Cap. | +0.31% | +1.86% | +2.33% | +9.43% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
59bf5.RPV3jfmnzX-7NrXzv7itFAtUAppJVTKvUmS_Cwh--os.DLAOy4vJ-T6PA9Gf9f_nR05jSqgeA1zlOw_YZHsPs8gqsxC9vtSYC41M_A
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 16:00:00 | 57.86 | 54,869 | 169,608 |
| 15:59:59 | 57.86 | 113 | 114,739 |
| 15:59:59 | 57.78 | 394 | 114,626 |
| 15:59:59 | 57.85 | 100 | 114,232 |
| 15:59:57 | 57.84 | 100 | 114,132 |
| 15:59:57 | 57.84 | 249 | 114,032 |
| 15:59:55 | 57.84 | 100 | 113,783 |
| 15:59:52 | 57.82 | 171 | 113,683 |
| 15:59:51 | 57.86 | 200 | 113,512 |
| 15:59:51 | 57.86 | 200 | 113,312 |
Monthly variations
Annual change
| 2024 | +45.52% | ||
| 2023 | -17.20% | ||
| 2022 | -17.93% | ||
| 2021 | -17.05% | ||
| 2020 | +251.29% |
- Stock Market
- Equities
- KROS Stock
- Quotes Keros Therapeutics, Inc.
